Fund managers bet on defensives

For the week, Rikesh Parikh’s net worth stands at Rs 949,000, down 5.11 per cent; Mehraboon Irani’s net worth is valued at Rs 805,000, down 19.46 per cent; Ashish Mittal’s net worth is at Rs 909,000, 9.11 per cent less; Alex Mathews’ is at Rs 983,000, down 1.73 per cent; and Ajay Parmar’s totals Rs 969,000, down 3.09 per cent.

RIKESH PARIKH,
VP, equity strategies, Motilal Oswal Securities
“The RBI policy was on expected lines. We are factoring in rate cuts, possibly in Jan–Feb, as headline inflation number has started showing signs of cooling down. I will retain holding in financials and would look to increase allocation at the time of the next policy meet. I have retained my holding in financial stocks,” said he, adding:

“In a falling market, defensive stocks are invested for generating relative gains, and so, I would prefer to be invested if valuations remain attractive and growth can be seen.” 

RIKESH PARIKH, VP Equity Strategies, Motilal Oswal Securities
Top Holdings	Cost price (Rs)	Current price (Rs)	Value  (Rs lakh)
Dena Bank	76.10	55.20	0.33
Mcleod Russel India	234.20	205.65	0.31
Coal India	339.94	299.95	0.30
State Bank of India	1783.97	1671.10	0.25
Deepak Fertilizers	166.16	124.30	0.25
Total investments			2.39
Cash			7.10
Net worth			9.49

ASHISH MITTAL,
fund manager – PMS, Centrum Wealth
“The RBI clearly indicated the monetary cycle was likely to reverse. I expect this to benefit sectors like auto, banking and real estate to some extent. More important, the lowering of interest rates would mean enhanced ability for the infrastructure sector to expedite delayed projects, as the capital becomes cheaper. However, I would still be on guard and slowly raise exposure to such sectors, once I feel fiscal concerns are beginning to be addressed by the government. I currently have exposure to Karur Vysya Bank, YES Bank and Bajaj Auto and will hold the same for some time before increasing exposure,” he said.

“Meanwhile, I continue to maintain investments in defensives, primarily high dividend yield and cash-rich companies, and would be investing further in companies like Balmer Lawrie, Bharat Electronics, Glaxo Pharma and ITC.”
 

ASHISH MITTAL, Fund Manager – PMS, Centrum Wealth
Top Holdings	Cost price (Rs)	Current price (Rs)	Value  (Rs lakh)
MRF	6816.10	6961.35	0.70
Balmer Lawrie & Company	618.48	489.40	0.64
Karur Vysya Bank	372.59	350.35	0.60
ITC	199.36	203.75	0.56
Bharat Electronics	1582.70	1392.05	0.56
Total investments			8.05
Cash			1.04
Net worth			9.09

ALEX MATHEWS,
head (technical and derivatives research), Geojit BNP Paribas Financial Services
“Given the situation of slowing industrial production and inflation showing signs of cooling, I expect RBI to lower key rates at its coming quarterly review on January 24. If that happens, we may see rate-sensitive sectors like bank, infrastructure, realty and auto witnessing some value buying. With this perspective, I have taken a long position in IB Real Estate,” he said. “Pharma and fast moving consumer goods stand out among defensives. But given the European crisis, the businesses are expected to be sluggish. If the pharmaceutical Bill is passed, we may see short- to medium-term impact on the revenues of pharma companies. But among pharma majors, I expect Cipla, Lupin and, even, Dr Reddy’s to show positive trends. I am waiting for the markets to consolidate before committing a large trade.”
 

ALEX MATHEWS, Head-Technical and Derivatives Research, Geojit BNP Paribas Financial Services
Top Holdings	Cost price (Rs)	Current price (Rs)	Value  (Rs lakh)
Indiabulls Real Estate	51.78	48.00	0.48
Tata Coffee	897.89	777.90	0.19
Bajaj Financial Services	571.78	414.75	0.10
Bharat Petroleum Corp	559.24	521.40	0.05
Larsen & Toubro	1385.51	1004.80	0.05
Total investments			0.88
Cash			8.95
Net worth			9.83

AJAY PARMAR,
co-head, investment banking, Emkay Global
“I think there is still some pain left for interest sensitives. All eyes will be now on third-quarter results, which would spell out a lot of pessimism, as corporate results are likely to be the worst in recent times. I believe the recent rise in the market is not sustainable,” he said.

“The defensives like consumers were perhaps the only place to hide in the current market condition. Unlike in 2008-09, pharma companies have not participated as a strong defensive play, as there was a moderation in domestic growth. I believe consumers is a good story with asset-light models, higher ROE (return on equity) and ROCE (return on capital employed), debt-free status and net cash positive earnings. Howe